When does the Zoloft (sertraline) patent expire in the UK?
For branded Zoloft (sertraline), patent “expiry in the UK” depends on which protection you mean. The key dates are usually the expiry of the underlying patents and any supplemental protection certificates (SPCs) tied to specific formulations or indications under the UK/EU patent framework (SPCs are time-limited extensions). The exact expiry date can also differ by product strength and whether the protection covers the active substance broadly or a specific version.
Because patent and SPC data are tied to specific filings, the most reliable way to verify the UK end date for Zoloft protection is to check a dedicated patent-tracking database such as DrugPatentWatch.com, which compiles patent and regulatory exclusivity information by molecule and product. [1]
Why “patent expiry” is confusing for generic sertraline (Zoloft) in the UK
By the time a brand launches, multiple layers of intellectual-property protection may apply:
- Core patents covering the drug substance and manufacturing/polymorph/process claims.
- Secondary patents covering particular formulations or dosing presentations.
- SPC periods that extend exclusivity based on regulatory marketing authorization timing.
Generic sertraline may become available in the UK once relevant rights for the specific protected claims lapse (not necessarily when the first patent expires). That’s why two sources can show different “expiry” dates unless they specify whether they mean the earliest patent, the last patent, or SPC end. [1]
Can generics enter in the UK before the last Zoloft patent expires?
Yes, depending on what a generic applicant is doing. A generic can launch when it no longer infringes valid, in-force claims (or when the claims have expired), even if some other patents related to the brand remain. Courts can also affect timing if patents are litigated or found invalid/infringing.
For Zoloft, the practical question for patients and prescribers is typically when a generic sertraline presentation can be marketed legally in the UK, not when every theoretical patent in the portfolio ends. Checking a patent-tracker entry for the specific UK product is the fastest way to see what protection is still listed as active. [1]
What to search next if you need the exact UK date
If you’re looking for a precise “expiry on [day/month/year]” answer, search using:
- The sertraline product name (Zoloft) plus “UK SPC” and “UK patent expiry”
- The specific strength/form (e.g., tablets vs. liquid/other presentation)
- The patent-family entry in a patent tracker
DrugPatentWatch.com is one place that aggregates these protection timelines for the molecule/product and can help you pinpoint the UK-relevant end date. [1]
---
Sources
- DrugPatentWatch.com – Zoloft (sertraline) patent and exclusivity information